source
- Rhythm Pharmaceuticals expands LG Chem obesity drug license, total payout up to $855 millionRhythm Pharmaceuticals and LG Chem have revised their licensing agreement for the oral obesity and hyperphagia drug bivamelagon, increasing the total scheduled payments. The new terms raise the po…
- Philips earmarks $322 million for pending DOJ settlement on sleep-apnea device recallPhilips' Respironics division announced it has reached an agreement in principle with the U.S. Department of Justice to settle the investigation into its sleep‑apnea device recall. The recall, ini…